MedPath

A clinical trial to study the effects of two drugs, Palsinuron and Mahavatvidhwans ras in patients suffering from Migraine.

Phase 3
Conditions
Health Condition 1: null- Migraine
Registration Number
CTRI/2012/06/002739
Lead Sponsor
SG Phytopharma Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1. Age between 18 years and 60 years

2. Both the sex

3. Patient with five or more attacks of Migraine(headache) without Aura lasting for 4- 72 hours presenting with

a) at least two of the features viz.

i) unilateral,

ii) Pulsating,

iii) Moderate to severe,

iv) Aggravated by movement and

b) at least one of the features viz.

i) Nausea,

ii) Photophobia,

iii) Phonophobia.

4. Patients willing to sign informed consent

Exclusion Criteria

1. Age below 18 and above 60 years

2. Less than five attacks of Migraine without Aura.

3. Clinically diagnosed cases

a. Tension headache

b. Cluster headache.

c. Idiopathic stabbing headache

d. Exertional headache.

e. Headache due to systemic infection.

f. Drug induced headache

4. Organic brain lesions

5. Systemic disorders

6. Person undergoing treatment for any other serious illness.

7. Patient not willing to sign informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EfficacyTimepoint: 30 Days
Secondary Outcome Measures
NameTimeMethod
SafetyTimepoint: 30 days
© Copyright 2025. All Rights Reserved by MedPath